Curative Biotechnology Stock Today
| CUBT Stock | USD 0.01 0.0003 2.22% |
Performance7 of 100
| Odds Of DistressOver 78
|
Curative Biotechnology is selling for under 0.0138 as of the 4th of January 2025; that is 2.22 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.0128. Curative Biotechnology has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 5th of November 2024 and ending today, the 4th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 20th of September 2017 | Category Healthcare | Classification Health Care |
Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 903.26 M outstanding shares. More on Curative Biotechnology
Moving against Curative Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Curative Stock Highlights
| President Chairman | Paul Michaels | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Curative Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Curative Biotechnology's financial leverage. It provides some insight into what part of Curative Biotechnology's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Curative Biotechnology (CUBT) is traded on NYSE MKT Exchange in USA and employs 4 people. Curative Biotechnology is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.56 M. Curative Biotechnology conducts business under Biotechnology sector and is part of Health Care industry. The entity has 903.26 M outstanding shares.
Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations.
Check Curative Biotechnology Probability Of Bankruptcy
Ownership AllocationCurative Biotechnology holds a total of 903.26 Million outstanding shares. Almost 99.95 percent of Curative Biotechnology outstanding shares are held by general public with 0.051 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Curative Ownership Details
Curative Biotechnology Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Curative Biotechnology market risk premium is the additional return an investor will receive from holding Curative Biotechnology long position in a well-diversified portfolio.
| Mean Deviation | 10.76 | |||
| Semi Deviation | 11.72 | |||
| Standard Deviation | 15.9 | |||
| Variance | 252.82 |
Curative Stock Against Markets
Curative Biotechnology Corporate Management
| BS BA | Vice Officer | Profile | |
| Pam Bisikirski | Vice Communications | Profile | |
| JD Esq | CFO, CEO | Profile | |
| Ronald Bordens | Executive Board | Profile |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.